glp-1 news 2025 november GLP-1 Drugs: 2025 Pulse Survey (U.S.) GLP-1 Agonists Market Report 2025-2033,

In January, FDA regulators gave the OK for another Novo Nordisk product, Wegovy, to be sold as an oral tablet

Circulation research

For example, if you need to be hospitalized with an IV to replace lost fluids and nutrients due to stomach paralysis, you can recuperate economic damages for those medical bills

AzegamiTYukiYSawadaSMejimaMIshigeKAkiyoshiKet al

Some large database analyses have suggested a modest increase in pancreatitis risk, particularly in the first few months after initiation, while others have found no association after adjusting for confounding factors such as obesity, gallbladder disease, and alcohol use